Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Ann Surg Oncol. 2021 Apr 5;28(11):5960–5971. doi: 10.1245/s10434-021-09897-w

Figure 1(a, b).

Figure 1(a, b).

Figure 1 presents ypN0, ypN1, and ypN2–3 disease rates for patients who presented with cN0 and cN+ disease and experienced a) breast pCR (N = 255) or b) breast RD (N = 270). Patients with missing clinic T category were excluded from this analysis.